обновлено 3 часа назад
Director, ADME
Мэтч & Сопровод
Для мэтча с этой вакансией нужен Plus
Описание вакансии
Текст:
TL;DR
Director, ADME (Drug Development): Building and leading Enveda’s ADME function to support discovery programs from promising chemistry through development-ready candidates with an accent on DMPK strategy, ADME studies, PK/PD, and bioanalysis. Focus on shaping scientific capabilities, developing the ADME organization, and guiding compound optimization and candidate selection.
Location: Hyderabad, India; on-site
Company
is a biotech startup developing medicines and advancing drug discovery programs, with its first drug in Phase 2 trials.
What you will do
- Provide scientific leadership on ADME–SAR and partner with Medicinal Chemistry to improve druggability and guide compound optimization.
- Define and execute DMPK strategies across early discovery, lead optimization, and candidate selection.
- Lead the design, execution, interpretation, and communication of in vitro and in vivo ADME studies.
- Develop PK/PD strategies and bioanalytical methods.
- Build and lead the ADME organization, including talent development, SOPs, laboratory capabilities, operations, and external partnerships.
- Oversee CAPEX/OPEX planning, data integrity, quality, safety, and audit readiness.
Requirements
- PhD in Pharmaceutical Sciences, Pharmacokinetics, Drug Metabolism, or a related scientific discipline.
- 15+ years of post-PhD experience in ADME/DMPK within drug discovery or development.
- Deep expertise across the drug discovery lifecycle and demonstrated experience building and leading ADME/DMPK functions.
- Strong understanding of bioanalysis, PK/PD, regulatory expectations, data integrity, safety, and quality requirements.
- Ability to influence and collaborate across Medicinal Chemistry, Pharmacology, Non-Clinical, and other scientific functions.
Culture & Benefits
- Values include curiosity, agency, journey, charity, and unity.
- Benefits include medical coverage, block leaves, and work-life harmony.
- has raised $150M in Series D funding and reached unicorn status.
Будьте осторожны: если работодатель просит войти в их систему, используя iCloud/Google, прислать код/пароль, запустить код/ПО, не делайте этого - это мошенники. Обязательно жмите "Пожаловаться" или пишите в поддержку. Подробнее в гайде →